-
Mashup Score: 0IgA Nephropathy Explained - 7 month(s) ago
Dr. Richard Lafayette, Director of the Stanford Glomerular Disease Center, describes the current standard of care for IgA nephropathy.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Nefecon For IgA Nephropathy Treatment - 7 month(s) ago
Dr. Richard Lafayette, Director of the Stanford Glomerular Disease Center, describes the use of Nefecon for IgA nephropathy treatment.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Richard Lafayette, MD, describes the latest clinical trial assessing Nefecon (budesonide delayed-release capsules) for immunoglobulin A #IgA nephropathy treatment #checkrare @IgNSorg https://t.co/5CebU3CQnJ
-
-
Mashup Score: 0Nefecon For IgA Nephropathy Treatment - 8 month(s) ago
Dr. Richard Lafayette, Director of the Stanford Glomerular Disease Center, describes the use of Nefecon for IgA nephropathy treatment.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Richard Lafayette, MD, describes the latest clinical trial assessing Nefecon (budesonide delayed-release capsules) for immunoglobulin A #IgA nephropathy treatment #checkrare @IgNSorg https://t.co/5CebU3CQnJ
-
-
Mashup Score: 0IgA Nephropathy Explained - 8 month(s) ago
Dr. Richard Lafayette, Director of the Stanford Glomerular Disease Center, describes the current standard of care for IgA nephropathy.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, and Rheumatologist at Stanford Health Care, describes the current standard of care for immunoglobulin A #IgA nephropathy #checkrare #rarediseases @IgNSorg @ikdrc_ahm https://t.co/eeMyDcEWvz
-
-
Mashup Score: 0
Dr. Jonathan Barratt, from University of Leicester, discusses data from a phase 2b trial evaluating atacicept to treat IgA nephropathy.
Source: CheckRare.comCategories: Latest Headlines, Rare DiseaseTweet-
Jonathan Barratt, Ph.D., FRCP, Professor of Renal Medicine, University of Leicester, UK, describes the latest results of phase 2b trial examining atacicept to treat immunoglobulin A #IgA nephropathy @IgNSorg https://t.co/JbKVYhmhlg
-
-
Mashup Score: 1Nefecon For IgA Nephropathy Treatment - 9 month(s) ago
Dr. Richard Lafayette, Director of the Stanford Glomerular Disease Center, describes the use of Nefecon for IgA nephropathy treatment.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Richard Lafayette, MD, describes the latest clinical trial assessing Nefecon (budesonide delayed-release capsules) for immunoglobulin A #IgA nephropathy treatment #checkrare @IgNSorg https://t.co/5CebU3CQnJ
-
-
Mashup Score: 0Atacicept Shows Promise as IgA Nephropathy Treatment in Interim Analysis - 10 month(s) ago
Dr. Jonathan Barratt, from University of Leicester, discusses data from a phase 2b trial evaluating atacicept to treat IgA nephropathy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Jonathan Barratt, Ph.D., FRCP, Professor of Renal Medicine, University of Leicester, UK, describes the latest results of phase 2b trial examining atacicept to treat immunoglobulin A #IgA nephropathy @IgNSorg https://t.co/JbKVYhmhlg
-
-
Mashup Score: 0Atacicept Shows Promise as IgA Nephropathy Treatment in Interim Analysis - CheckRare - 11 month(s) ago
Dr. Jonathan Barratt, from University of Leicester, discusses data from a phase 2b trial evaluating atacicept to treat IgA nephropathy.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Jonathan Barratt, Ph.D., FRCP, Professor of Renal Medicine, University of Leicester, UK, describes the latest results of phase 2b trial examining atacicept to treat immunoglobulin A #IgA nephropathy @IgNSorg https://t.co/JbKVYhmhlg
-
-
Mashup Score: 1Immunoglobulin A (IgA) Nephropathy Explained - 11 month(s) ago
Dr. Jonathan Barratt, from University of Leicester in the UK, gives an overview of immunoglobulin A (IgA) nephropathy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Jonathan Barratt, PhD, FRCP, Professor of Renal Medicine, University of Leicester, UK, gives an overview of immunoglobulin A #IgA nephropathy #checkrare #rarediseases @IgNSorg https://t.co/C1L7aesdvF
-
-
Mashup Score: 0Atacicept Shows Promise as IgA Nephropathy Treatment in Interim Analysis - 11 month(s) ago
Dr. Jonathan Barratt, from University of Leicester, discusses data from a phase 2b trial evaluating atacicept to treat IgA nephropathy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Jonathan Barratt, Ph.D., FRCP, Professor of Renal Medicine, University of Leicester, UK, describes the latest results of phase 2b trial examining atacicept to treat immunoglobulin A #IgA nephropathy @IgNSorg https://t.co/JbKVYhmhlg
-
Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, and Rheumatologist at Stanford Health Care, describes the current standard of care for immunoglobulin A #IgA nephropathy #checkrare #rarediseases @IgNSorg @ikdrc_ahm https://t.co/eeMyDcEWvz